OxLDL enhances procoagulant activity of endothelial cells by TMEM16F‐mediated phosphatidylserine exposure
Cell Biology International · 2024
DOI: 10.1002/cbin.12150 ↗At a glance
Journal article in Cell Biology International, 2024. Written by Meishan Yan and 11 co-authors. Institution: Department of Medical Laboratory Science and Technology, Harbin Medical University Daqing, Daqing, China. Major MEDLINE topics: Anoctamins, Endothelial Cells, Lipoproteins, LDL, Phosphatidylserines. Cited 5 times so far (Crossref); 49 references. Funded by: Center of diagnosis and treatment of disease in cold place, National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province.
Abstract (original language)
Oxidized low‐density lipoprotein (oxLDL), a key component in atherosclerosis and hyperlipidemia, is a risk factor for atherothrombosis in dyslipidemia, yet its mechanism is poorly understood. In this study, we used oxLDL‐induced human aortic endothelial cells (HAECs) and high‐fat diet (HFD)‐fed mice as a hyperlipidemia model. Phosphatidylserine (PS) exposure, cytosolic Ca 2+ , reactive oxygen species (ROS), and lipid peroxidation were measured by flow cytometer. TMEM16F expression was detected by immunofluorescence, western blot, and reverse transcription polymerase chain reaction. Procoagulant activity (PCA) was measured by coagulation time, intrinsic/extrinsic factor Xase, and thrombin generation. We found that oxLDL‐induced PS exposure and the corresponding PCA of HAECs were increased significantly compared with control, which could be inhibited over 90% by lactadherin. Importantly, TMEM16F expression in oxLDL‐induced HAECs was upregulated by enhanced intracellular Ca 2+ concentration, ROS, and lipid peroxidation, which led to PS exposure. Meanwhile, the knockdown of TMEM16F by short hairpin RNA significantly inhibited PS exposure in oxLDL‐induced HAECs. Moreover, we observed that HFD‐fed mice dramatically increased the progress of thrombus formation and accompanied upregulated TMEM16F expression by thromboelastography analysis, FeCl 3 ‐induced carotid artery thrombosis model, and western blot. Collectively, these results demonstrate that TMEM16F‐mediated PS exposure may contribute to prothrombotic status under hyperlipidemic conditions, which may serve as a novel therapeutic target for the prevention of thrombosis in hyperlipidemia.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medical Laboratory Science and Technology, Harbin Medical University Daqing, Daqing, China.
- Hematology Department, Daqing Oil Field General Hospital, Daqing, China.
- Department of Emergency, The Fifth Affiliated Hospital of Harbin Medical University, Daqing, China.
ORCID profiles: Chunyan Gao
Funding
- Center of diagnosis and treatment of disease in cold place
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
- Marshal Initiative Funding
- PhD Fund of Harbin Medical University-Daqing
- Heilongjiang Provincial Postdoctoral Science Foundation
- Key Discipline Construction Project of Harbin Medical University-Daqing
- The Fundamental Research Funds for the Provincial Universities
Cite
APA
Yan, M., Wang, Z., An, Y., Li, Z., Li, Y., Zhang, H., Li, C., Wang, L., Chen, L., Gao, C., Wang, D., & Gao, C. (2024). OxLDL enhances procoagulant activity of endothelial cells by TMEM16F‐mediated phosphatidylserine exposure. Cell Biology International. https://doi.org/10.1002/cbin.12150
Vancouver
Yan M, Wang Z, An Y, Li Z, Li Y, Zhang H, et al. OxLDL enhances procoagulant activity of endothelial cells by TMEM16F‐mediated phosphatidylserine exposure. Cell Biology International. 2024. doi:10.1002/cbin.12150
BibTeX
@article{Yan2024,
author = {Yan, Meishan and Wang, Zelong and An, Yao and Li, Zhanni and Li, Yun and Zhang, Hongyu and Li, Caixia and Wang, Lifeng and Chen, Li and Gao, Chao and Wang, Dongsheng and Gao, Chunyan},
title = {OxLDL enhances procoagulant activity of endothelial cells by TMEM16F‐mediated phosphatidylserine exposure},
journal = {Cell Biology International},
year = {2024},
doi = {10.1002/cbin.12150}
}
EUVIMED